Growth Metrics

Arcadia Biosciences (RKDA) Long-Term Debt Repayments (2019 - 2021)

Arcadia Biosciences' Long-Term Debt Repayments history spans 3 years, with the latest figure at $114000.0 for Q4 2021.

  • For Q4 2021, Long-Term Debt Repayments rose 1325.0% year-over-year to $114000.0; the TTM value through Dec 2021 reached $2.1 million, up 6211.76%, while the annual FY2021 figure was $2.1 million, 6211.76% up from the prior year.
  • Long-Term Debt Repayments reached $114000.0 in Q4 2021 per RKDA's latest filing, up from $13000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.0 million in Q1 2021 to a low of $6000.0 in Q4 2019.
  • Average Long-Term Debt Repayments over 3 years is $242888.9, with a median of $10000.0 recorded in 2021.
  • The largest YoY upside for Long-Term Debt Repayments was 28600.0% in 2021 against a maximum downside of 18.18% in 2021.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $6000.0 in 2019, then soared by 33.33% to $8000.0 in 2020, then surged by 1325.0% to $114000.0 in 2021.
  • Per Business Quant, the three most recent readings for RKDA's Long-Term Debt Repayments are $114000.0 (Q4 2021), $13000.0 (Q3 2021), and $10000.0 (Q2 2021).